PubMed ID: 39301823
Author(s): Botros E, Bradfield Y, Pytel N. Cataract Formation in a Child Receiving Dabrafenib and Trametinib Therapy. J Pediatr Ophthalmol Strabismus. 2024 Sep-Oct;61(5):e47-e49. doi: 10.3928/01913913-20240722-01. Epub 2024 Sep 1. PMID 39301823
Journal: Journal Of Pediatric Ophthalmology And Strabismus, Volume 61, Issue 5, 2024
The authors report a case of bilateral cataract in a 9-year-old girl after being treated with a combination of the targeted therapy drugs dabrafenib and trametinib. Although adverse effects have been reported with this treatment, this report is the first documented case of cataract as a complication. [J Pediatr Ophthalmol Strabismus. 2024;61(5):e47-e49.].